Actualité

EMBALL`ISO S.A. （本社：St-Georges-de-Reneins（フランス）、代表者：Pierre CASOLI）は2021年1月に日本子会社EMBALL`ISO JAPAN（アンバリゾジャパン）株式会社を設立、同年9月からはカントリーマネージャーに堀田修二が就任し日本における事業立ち上げを行っていきます。

Brexit, Covid and the Environment have brought a lot of new challenges.

As the pharmaceutical industry leapt up to meet the challenge of developing a vaccine to combat a global pandemic, its partners in the supply chain had to keep in step. Yann Martin, global sales director of isothermal solutions supplier EMBALL’ISO, tells us how the company ramped up its operations to cope with the surge in demand.

Discover how industry experts address the challenge of COVID-19 vaccine distribution and especially how EMBALL’ISO Reuse and Reverse Network can help make this distribution greener.

In 2021, we will continue to grow and develop to support you where you are.

Register to the webinar

When a COVID-19 vaccine is developed and ready for distribution it will, in all likelihood, require cold chain services.

FREE Webinar on Tuesday 20 October 2020, 15:00 BST | 16:00 CEST | 10:00 EDT

The designer and manufacturer of innovative high-performance isothermal solutions for transporting heat-sensitive pharmaceutical products EMBALL'ISO, is committed to fulfilling the needs of pharmaceutical laboratories, relating to the Covid-19 pandemic.

The new High Performance Pallet Shipper is validated under ISTA 7D profile for transportation in Cool (+2°C/+8°C), Temperate (+15°C/+25°C) and Freeze temperature (without dry ice).